Who Angelini Ventures is
Angelini Ventures invests 300 million euros globally in biotech and health tech, with managing directors in Rome, Geneva, Munich, and Singapore. Its October 2026 deals also included Nouscom and RougeTx.1
Deals this month
| Company | Round | Amount | Role | Announced |
|---|---|---|---|---|
| MMI | Series D | $125M | New investor | October 8, 20264 |
Robotics bet this month
Angelini Ventures joined MMI's $125 million Series D as a new investor. The round includes a 17 million euro co-investment that Angelini Ventures announced with the European Investment Bank in September 2026.2,4
Managing director Tanja Dowe sits on MMI's board. MMI was founded near Pisa and still manufactures Symani there, which makes the deal a bet on an Italian-born device that now sells mainly in the US.3,2